Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer-Reference-Cited by-同舟云学术

Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer

Published:2019-03-25 Issue:1 Volume:273 Page:154-162
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Klaiber Ulla,Schnaidt Eva S.,Hinz Ulf,Gaida Matthias M.,Heger Ulrike,Hank Thomas,Strobel Oliver,Neoptolemos John P.,Mihaljevic André L.,Büchler Markus W.,Hackert Thilo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference47 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS);Bockhorn;Surgery,2014

3. Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients;Hackert;Ann Surg,2016

4. Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial;Murphy;JAMA Oncol,2018

5. Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma;Epstein;J Surg Oncol,2017

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraoperative end-tidal carbon dioxide levels are not associated with recurrence-free survival after elective pancreatic cancer surgery: a retrospective cohort study;Frontiers in Medicine;2024-09-11

2. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX;Journal of Clinical Medicine;2024-09-02

3. Optimal timing of surgery after neoadjuvant treatment in borderline resectable pancreatic cancer;Journal of Hepato-Biliary-Pancreatic Sciences;2024-07-21

4. Integrated 68Ga-FAPI-04 PET/MR in Pancreatic Cancer;Clinical Nuclear Medicine;2024-06-21

5. 膵臓癌（浸潤性膵管癌）に対する術前化学療法とConversion surgery;Nihon Ika Daigaku Igakkai Zasshi;2024-04-25